Introduction:
Softgel fill weight is whether each unit receives a repeatable mass of fill. Seam integrity describes whether the sealed ribbon junction remains intact and prevents loss of fill. A softgel manufacturer should control those as separate quality attributes, together with assay where the specification names an active.
A useful softgel specification separates four things: target fill mass, active assay, uniformity where applicable, and seam/leak integrity. Each needs its own method, stage, acceptance criterion, and release decision.
Quick answer: Consistent net fill weights show that the filling process is delivering a repeatable mass. They do not establish active assay or content uniformity. A named seam or leak check addresses physical integrity as a separate attribute. Limits, methods, and release decisions live in the approved specification. There is no universal RSD on this page. [2]
Key takeaways
- Gross weight, shell contribution, and net fill weight are different masses. Shell mass still moves as the unit dries.
- Fill mass, active assay, unit-to-unit uniformity (when specified), and seam integrity answer different questions.
- Acceptance criteria are product-specific and belong in the approved specification.
- The specification defines what the lot must meet; a CoA reports the tests and results included for that lot.
- You do not need to finalize the fill-weight tolerance, IPC frequency, or seam test method before requesting a review.
Softgel Fill Weight: Gross, Shell Contribution and Net Fill
Buyers often say “capsule weight” as if it were one number. For a softgel it is at least three.
Gross weight
The filled unit as weighed: shell plus fill, at a defined moisture state.
Shell contribution
The shell contribution used for net-fill calculation must be defined by the approved measurement procedure. Gross weight = shell + fill. Net fill weight = gross weight − that shell contribution. The contribution depends on the defined measurement state and tare methodology. Softgel shells change mass as they dry, so the measurement state has to be justified. The method belongs in the batch record.
Net fill weight
Gross minus the justified shell contribution. This is the mass-control measurement used to evaluate whether the filling system is delivering the intended quantity consistently.
Target fill weight is a mass. Die cavity is a volume. Density connects them; the commercial die is confirmed on trial — how to choose softgel size. This page does not run that volume math.
How Fill-Weight Variation Is Evaluated
Fill-weight variation (also searched as fill-weight uniformity, softgel weight variation, or fill-weight tolerance) is the spread of individual net fills in a defined sample against the target and the acceptance criteria in the specification.
Typical evaluation language — when the specification uses it — includes individual results, the mean, and a measure of spread. Relative standard deviation (RSD) is one statistical measure of spread; it is not, by itself, a universal acceptance criterion. Dietary-supplement CGMP requires you to establish specifications and to test against those specifications. It does not publish a universal softgel RSD, ±% window, or IPC interval. [2]
Use the approved product-specific acceptance criterion rather than a generic RSD copied from another SKU or from a hard-capsule weight story.
What usually causes fill-weight drift
The first question is not “How do we widen the tolerance?” but “What process variable is causing the variation?” Investigate by cause category. Changing only the target average does not close the file.
Formulation-related
Viscosity change, temperature sensitivity, or suspension behavior that alters how the fill meters.
Equipment-related
Pump or dosing behavior, and whether the fill system is delivering a consistent shot.
Ribbon-related
Ribbon thickness or condition, and the moisture state of the shell at the time of weighing.
Measurement-related
Tare methodology, moisture state, and weighing conditions.
Fill-weight drift and seam defects should be investigated as separate process signals rather than assumed to share one cause. Leak diagnosis sits on the failure page.
Four Softgel QC Attributes: What Each One Proves
These four attributes are not interchangeable. This is the only full comparison on this page; later sections say how to specify them.
Net fill weight — mass
Question answered: How much fill mass entered each unit?
What it supports: Repeatability of the filling process.
Does not prove: Assay, unit-to-unit active uniformity, or seam integrity.
Active assay — chemistry
Question answered: How much of the named active is present?
What it supports: Chemical content against the approved method.
Does not prove: Fill-weight variation or a leak check.
Unit-to-unit active uniformity — distribution
Question answered: Is the active distributed consistently between units?
What it supports: Content uniformity or another unit-to-unit uniformity approach, when specified, and may be particularly relevant for suspensions and low-dose fills.
Does not imply: that a pharmacopeial uniformity test is required for every nutraceutical lot. Uniformity-of-dosage-units chapters apply to official articles and to files that adopt them. [2][4]
Seam / leak integrity — physical seal
Question answered: Is the shell properly sealed?
What it supports: Sealed-seam and leak risk as specified (visual and/or named integrity check).
Does not prove: Fill-weight or assay.
For a homogeneous solution, consistent fill mass can reduce one source of unit-to-unit variation, but it does not replace active assay. In a suspension, a unit can meet target fill weight while receiving a different proportion of active solids.
Why Suspensions Need Additional Control
A suspension can look uniform in a beaker and still segregate in the vessel, the line, or the sample. Settling, particle distribution, agitation, viscosity, and sampling position and time all change what the assay sees.
A uniform-looking sample is not enough if the sampling point does not represent the bulk during production. This is particularly important when a low-dose active is dispersed through a much larger carrier mass.
Whether the fill should be a solution or a suspension at all is a feasibility question — oil fill vs suspension softgels. This page only covers why a suspension that already runs still needs an assay (and, when specified, a uniformity) file beside weight.
How to Specify Softgel Seam Integrity
Seam integrity (also searched as seal integrity) describes whether the sealed ribbon junction remains intact and prevents loss of fill. Leakage is the commercial failure when it does not, or when the film later opens. Fill-weight control does not prove the seal.
Visual inspection evaluates observable seam condition; an integrity test evaluates whether the sealed unit meets the defined physical integrity requirement.
How to diagnose leak vs weep vs pack failure sits on why softgels leak. This page only covers what a seam requirement should define.
What a seam integrity requirement should define
- Inspection / test method (visual seam review and/or a named integrity test)
- Stage (IPC, release, or both)
- Sampling approach
- Acceptance criterion
- Release / defect decision
The exact method depends on the product specification and qualified process. This page does not prescribe a universal leak-test pressure, time, or sample count.
In-Process Controls vs Finished-Product Release
In-process controls detect process drift before the batch is completed — fill-mass trend, appearance, seam condition, and any other IPC the specification names. Frequency belongs in the batch record.
Release testing follows the approved product specification, applicable market requirements, and any agreed customer specifications. Pharmacopeial dissolution, rupture, or related dosage-form tests should be included only when applicable to the product specification and market requirements. [2]
Step order of encapsulation lives on how softgels are made. This page is the control file: which result answers which quality question.
How to Write a Softgel QC Specification
A usable quality specification names the attribute, the method, the stage, the acceptance criteria, and the release decision. “Check fill weight” or “no leaks” is not complete. This structure applies to fill weight, assay, uniformity, and seam integrity alike.
Each attribute in the specification should define:
1. Attribute
What is being controlled — for example net fill weight, active assay, or seam integrity.
2. Target
The product-specific target (fill mass, active amount, or integrity requirement).
3. Method
The approved weighing, analytical, or integrity method for that SKU.
4. Stage
IPC, finished-product release, or both, as agreed.
5. Acceptance criterion
The product-specific approved limit — not a generic percentage copied from another factory.
6. Sampling approach
Defined in the approved specification and batch record.
7. Release decision
Pass or fail against the approved specification.
Example RFQ language (not a KS standard limit)
Fill weight. Target fill weight: [X mg] net fill weight. Measurement basis: net fill weight. Acceptance criterion: per approved product specification. Stage: IPC and/or finished-product release as agreed.
Active assay. Active: [ingredient]. Method: [approved method]. Acceptance: [product-specific specification]. Content uniformity or another unit-to-unit uniformity approach: include only when that risk is in the file.
Seam integrity. Visual seam inspection plus the applicable integrity test, if specified. Method, stage, acceptance criterion, and release decision: to be agreed during specification approval.
If you already have a finished-product specification, send it. If you do not, send the formula, target fill weight, active specification if available, and target market. The manufacturer can help convert those inputs into a production specification.
Specification vs CoA: Do Not Treat Them as the Same Document
Specification defines what the product is required to meet: test, method, acceptance criterion, stage, and release requirement.
A CoA reports the tests performed and results reported for that lot: lot identity, test, result, and — where applicable — the specification reference or acceptance status.
A CoA can demonstrate conformity only for the attributes and results reported against the applicable specification. It does not demonstrate unreported attributes. Passing weight does not imply passing assay; passing assay does not imply seam integrity — those lines appear only if they were specified and reported.
A CoA without the corresponding specification is difficult to interpret because the result has no acceptance context.
How to read identity, method, spec, and result columns sits on how to read a COA. This page only bounds what a finished-softgel CoA can and cannot stand in for.
What Should You Send to the Manufacturer?
You do not need to finalize the fill-weight tolerance, IPC frequency, or seam test method before requesting a review. If you have an existing specification, send it. If not, send the formula, target fill weight, active specification if available, and target market.
- Active ingredient and active specification, if available
- Fill type: oil solution or suspension
- Target fill weight; active concentration if known
- Softgel size or die, if already chosen
- Shell type
- Packaging
- Target market
- Estimated order volume
- Existing specification or CoA template, if any
Request a Softgel Specification Review
What you provide: formula, target dose, active specification if available, and market — plus an existing specification if one exists.
What we review: fill type, fill weight, assay, uniformity risk, and seam requirements.
What you receive: manufacturing specification inputs, QC requirements, and quotation.
KS Nutripharma can review the brief, recommend the applicable quality-control parameters, and prepare the softgel specification and quotation for softgel manufacturing.
Request a Softgel Specification Review
Related Softgel Manufacturing Guides
- What Are Softgels Made Of?
- Gelatin vs Vegetarian Softgels
- Oil Fill vs Suspension Softgels
- How to Choose Softgel Size
- How Softgels Are Made
- Why Softgels Leak
- Softgel vs Hard Capsule
- How to Read a COA
No. Consistent net fill weight shows filling-process repeatability. Assay of the named active is a separate attribute. Content uniformity or another unit-to-unit uniformity approach applies only when that test is in the specification, and may be particularly relevant for a suspension.
No. Acceptance criteria are product-specific. Dietary-supplement CGMP requires specifications and testing against them; it does not publish a universal RSD. [2]
Yes. The manufacturer can help establish it as part of product-specification development, provided the final criterion is agreed and documented in the approved specification. It should be based on the formulation, manufacturing process, measurement method, and applicable market requirements — not copied from a generic online tolerance.
Formula, target fill weight, active specification if available, fill type, shell requirement, target market, and any existing CoA or specification are enough to start a manufacturing review. Exact IPC and release criteria can be finalized during specification development.
No. It only demonstrates the reported tests against the applicable specification. A weight or assay line does not replace a seam check that was never specified.
